GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Organigram Global Inc (TSX:OGI) » Definitions » EV-to-EBITDA

Organigram Global (TSX:OGI) EV-to-EBITDA : 34.23 (As of May. 31, 2025)


View and export this data going back to 2011. Start your Free Trial

What is Organigram Global EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Organigram Global's enterprise value is C$240.5 Mil. Organigram Global's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was C$7.0 Mil. Therefore, Organigram Global's EV-to-EBITDA for today is 34.23.

The historical rank and industry rank for Organigram Global's EV-to-EBITDA or its related term are showing as below:

TSX:OGI' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1025.7   Med: -1.12   Max: 2693.81
Current: 34.23

During the past 12 years, the highest EV-to-EBITDA of Organigram Global was 2693.81. The lowest was -1025.70. And the median was -1.12.

TSX:OGI's EV-to-EBITDA is ranked worse than
81.9% of 735 companies
in the Drug Manufacturers industry
Industry Median: 13.98 vs TSX:OGI: 34.23

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-31), Organigram Global's stock price is C$1.83. Organigram Global's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was C$0.050. Therefore, Organigram Global's PE Ratio (TTM) for today is 36.60.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Organigram Global EV-to-EBITDA Historical Data

The historical data trend for Organigram Global's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Organigram Global EV-to-EBITDA Chart

Organigram Global Annual Data
Trend Apr14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Sep24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 69.28 -2.98 -8.61 31.95 -6.91

Organigram Global Quarterly Data
Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.86 -7.33 -6.91 -112.68 27.36

Competitive Comparison of Organigram Global's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Organigram Global's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Organigram Global's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Organigram Global's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Organigram Global's EV-to-EBITDA falls into.


;
;

Organigram Global EV-to-EBITDA Calculation

Organigram Global's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=240.491/7.025
=34.23

Organigram Global's current Enterprise Value is C$240.5 Mil.
Organigram Global's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$7.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Organigram Global  (TSX:OGI) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Organigram Global's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.83/0.050
=36.60

Organigram Global's share price for today is C$1.83.
Organigram Global's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.050.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Organigram Global EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Organigram Global's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Organigram Global Business Description

Traded in Other Exchanges
Address
145 King Street West, Suite 1400, Toronto, ON, CAN, M5H 1J8
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
Executives
Dexter John Director
Beena Goldenberg Senior Officer
Sherry Porter Director
Stephen A. Smith Director
Gregory Guyatt Senior Officer
Paolo De Luca Senior Officer
Katrina May Mcfadden Senior Officer
Donald Geoffrey Machum Director
Derrick West Senior Officer
Michel Bourque Director
Kenneth Arnold Mitton Director
Denis Joseph Robert Arsenault 10% Security Holder, Director, Senior Officer